Junine Toy

477 total citations
20 papers, 164 citations indexed

About

Junine Toy is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Junine Toy has authored 20 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 14 papers in Epidemiology and 6 papers in Virology. Recurrent topics in Junine Toy's work include HIV/AIDS Research and Interventions (15 papers), HIV, Drug Use, Sexual Risk (8 papers) and HIV/AIDS drug development and treatment (8 papers). Junine Toy is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), HIV, Drug Use, Sexual Risk (8 papers) and HIV/AIDS drug development and treatment (8 papers). Junine Toy collaborates with scholars based in Canada, United States and China. Junine Toy's co-authors include Rolando Barrios, Julio Montaner, Viviane D. Lima, Silvia Guillemi, Benita Yip, Katherine J. Lepik, Linda Akagi, Lu Wang, P. Richard Harrigan and Wendy W. Zhang and has published in prestigious journals such as PLoS ONE, Social Science & Medicine and AIDS.

In The Last Decade

Junine Toy

16 papers receiving 163 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junine Toy Canada 6 140 95 50 27 17 20 164
Anna Tostevin United Kingdom 10 229 1.6× 195 2.1× 74 1.5× 27 1.0× 14 0.8× 18 258
David Dorey Canada 6 112 0.8× 74 0.8× 43 0.9× 24 0.9× 5 0.3× 10 156
Nália Ismael Mozambique 8 147 1.1× 63 0.7× 101 2.0× 11 0.4× 43 2.5× 20 183
Shalton Mwaringa United Kingdom 6 143 1.0× 123 1.3× 46 0.9× 6 0.2× 11 0.6× 7 182
Suzanne M. McCluskey United States 11 168 1.2× 134 1.4× 40 0.8× 11 0.4× 8 0.5× 29 202
Linda Harrison United States 7 253 1.8× 217 2.3× 57 1.1× 14 0.5× 8 0.5× 10 290
Olivier Ségéral France 10 180 1.3× 118 1.2× 91 1.8× 5 0.2× 19 1.1× 28 242
Nicolas Salvadori Thailand 9 123 0.9× 39 0.4× 66 1.3× 7 0.3× 10 0.6× 23 169
Adriana Durán Argentina 8 180 1.3× 136 1.4× 33 0.7× 8 0.3× 14 0.8× 13 211
Supunnee Jirajariyavej Thailand 8 139 1.0× 110 1.2× 41 0.8× 9 0.3× 11 0.6× 13 184

Countries citing papers authored by Junine Toy

Since Specialization
Citations

This map shows the geographic impact of Junine Toy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junine Toy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junine Toy more than expected).

Fields of papers citing papers by Junine Toy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junine Toy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junine Toy. The network helps show where Junine Toy may publish in the future.

Co-authorship network of co-authors of Junine Toy

This figure shows the co-authorship network connecting the top 25 collaborators of Junine Toy. A scholar is included among the top collaborators of Junine Toy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junine Toy. Junine Toy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montaner, Julio, Viviane D. Lima, Kate Salters, et al.. (2025). Generalized Treatment as Prevention Plus Focused Pre-Exposure Prophylaxis Is the Key to Controlling HIV/AIDS. Tropical Medicine and Infectious Disease. 10(3). 75–75. 1 indexed citations
2.
Leung, Victor C. M., Junine Toy, Peter Phillips, & Joan Montaner. (2025). Doxycycline postexposure prophylaxis to prevent bacterial sexually transmitted infections. Canadian Medical Association Journal. 197(19). E534–E535.
3.
4.
5.
6.
Toy, Junine, Katherine J. Lepik, David Moore, et al.. (2023). Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada. PLoS ONE. 18(3). e0283025–e0283025. 3 indexed citations
7.
8.
Emerson, Scott D., Taylor McLinden, Paul Sereda, et al.. (2023). Identification of people with low prevalence diseases in administrative healthcare records: A case study of HIV in British Columbia, Canada. PLoS ONE. 18(8). e0290777–e0290777. 2 indexed citations
9.
Montoya, Vincent, Junine Toy, Sarah Stone, et al.. (2022). Impact of SARS-CoV-2 lockdown on expansion of HIV transmission clusters among key populations: A retrospective phylogenetic analysis. The Lancet Regional Health - Americas. 16. 100369–100369. 7 indexed citations
10.
Kwok, Kevin W.H., et al.. (2022). Risk Factors, Screening, Diagnosis, and Treatment of Osteoporosis in HIV-Infected Adults in an HIV Primary Care Clinic. The Canadian Journal of Hospital Pharmacy. 75(3). 178–185.
11.
Lepik, Katherine J., Lu Wang, Taylor McLinden, et al.. (2022). Evolving patterns of antiretroviral drug interactions in people with HIV in British Columbia, Canada. AIDS. 36(8). 1105–1115. 3 indexed citations
12.
Thompson, Kyle A., Junine Toy, David Moore, et al.. (2022). Prevalence and incidence of hepatitis C infection amongst men who have sex with men in a population‐based pre‐exposure prophylaxis program in British Columbia, Canada. Liver International. 42(7). 1528–1535. 9 indexed citations
13.
Thompson, Kyle A., Junine Toy, David Moore, et al.. (2021). Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada. Open Forum Infectious Diseases. 8(11). ofab492–ofab492. 3 indexed citations
14.
Lepik, Katherine J., et al.. (2021). Untimed Efavirenz Drug Levels After Switching From Brand to Generic Formulations: A Short Communication. Therapeutic Drug Monitoring. 43(5). 701–705. 1 indexed citations
15.
Lepik, Katherine J., Benita Yip, Ana Cecilia Ulloa, et al.. (2018). Adverse drug reactions to integrase strand transfer inhibitors. AIDS. 32(7). 903–912. 29 indexed citations
16.
Lepik, Katherine J., P. Richard Harrigan, Benita Yip, et al.. (2017). Emergent drug resistance with integrase strand transfer inhibitor-based regimens. AIDS. 31(10). 1425–1434. 78 indexed citations
17.
Lepik, Katherine J., Benita Yip, Erin Ding, et al.. (2014). Post-Marketing Experience with Nevirapine Extended Release (XR) Tablets: Effectiveness and Tolerability in a Population-Based Cohort in British Columbia, Canada. Antiviral Therapy. 20(7). 721–730. 4 indexed citations
18.
Harris, Marianne, Junine Toy, Silvia Guillemi, et al.. (2013). Evaluation of Treatment Tolerability, Satisfaction and Laboratory Parameters in HIV+ Patients Switching from Ritonavir Capsule to Tablet Formulation§. Current HIV Research. 11(3). 231–237.
19.
Racey, C. Sarai, Wendy Zhang, Kimberly A. Fernandes, et al.. (2010). HIV antiviral drug resistance: patient comprehension. AIDS Care. 22(7). 816–826. 14 indexed citations
20.
Hull, Mark, et al.. (2008). Rapid rebound in hepatitis B DNA in previously undetectable hepatitis B/HIV co-infected patients switching from tenofovir to entecavir therapy. Journal of the International AIDS Society. 11(Suppl 1). P271–P271. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Tostevin Breakdown of academic impact, for papers by David Dorey Breakdown of academic impact, for papers by Nália Ismael Breakdown of academic impact, for papers by Shalton Mwaringa Breakdown of academic impact, for papers by Suzanne M. McCluskey Breakdown of academic impact, for papers by Linda Harrison Breakdown of academic impact, for papers by Olivier Ségéral Breakdown of academic impact, for papers by Nicolas Salvadori Breakdown of academic impact, for papers by Adriana Durán Breakdown of academic impact, for papers by Supunnee Jirajariyavej
Rankless by CCL
2026